Obalon Therapeutics OverviewObalon Therapeutics Other Income Expense Net
Other Income/Expense Net for OBLN.
Quarterly Other Income/Expense
$141814.00
↓ 95.73% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
-$3.30M
↓ 214.1% YoY
Trailing 12 months ending Mar 31, 2026